The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
David
Churchward,
Global Head Sterility Assurance, Cell and Gene Technologies,
Lonza Biologics
Jim
Collins,
President,
Pharmaceutical Delivery Systems LLC
Dr. Matthew
Hepburn,
M.D.,
Senior Advisor To the OSTP Director on Pandemic Prevention,
U.S. Office of Science and Technology Policy, Executive Office of the President
Martin
Johnson,
PhD,
VP - Engineering, Synthetic Molecule Design and Development,
Eli Lilly